What Causes Breast Milk Jaundice -

The exact cause of breast milk jaundice is not fully understood, but several factors are thought to contribute to its development:

The leading theory regarding the cause of breast milk jaundice involves an enzyme called .

The definitive pathway: Bilirubin (from broken red blood cells) is fat-soluble and toxic. To excrete it, the liver enzyme converts it into water-soluble conjugated bilirubin (direct bilirubin). Breast milk jaundice occurs when components in human milk non-competitively inhibit UGT1A1 activity in the infant's immature liver. what causes breast milk jaundice

The specific causes of breast milk jaundice are generally attributed to substances in the milk itself and how the infant's body processes them. Here is a detailed breakdown of the causes:

| Component in Breast Milk | Proposed Mechanism | Evidence Strength | |--------------------------|--------------------|-------------------| | | This enzyme de-conjugates bilirubin in the infant's gut. Normally, conjugated bilirubin (excreted in bile) is passed in stool. Beta-glucuronidase reverses this, turning it back into fat-soluble unconjugated bilirubin, which is reabsorbed from the intestine (enterohepatic circulation). | Strongest – Levels are 10–20x higher in milk of mothers whose infants develop BMJ. Activity correlates with bilirubin levels. | | 2. Non-esterified long-chain polyunsaturated fatty acids (e.g., EPA, DHA) | These fatty acids and their metabolites (like sulfated steroids) directly inhibit UGT1A1 enzyme activity in hepatocyte assays. The inhibition is reversible and dose-dependent. | Moderate-strong – Seen in vitro and in animal models. Explains why BMJ resolves when milk is temporarily stopped (heat-labile component? No – fatty acids are heat-stable, but other factors differ). | | 3. Interleukin-1 beta (IL-1β) & TNF-alpha | Pro-inflammatory cytokines in some milk may downregulate UGT1A1 gene expression or increase intestinal permeability, enhancing bilirubin reabsorption. | Emerging – Higher in BMJ-associated milk; may act synergistically with fatty acids. | | 4. Epidermal Growth Factor (EGF) | EGF delays maturation of intestinal tight junctions in neonates, paradoxically increasing paracellular absorption of unconjugated bilirubin from the gut lumen. | Moderate – EGF is higher in BMJ milk; animal knockouts show reduced jaundice. | | 5. Pregnanediol (a progesterone metabolite) | Earlier hypothesis (1970s) suggested this steroid inhibits UGT1A1. Later studies found no consistent elevation in BMJ milk. | Weak / historical – Largely discarded as primary cause. | The exact cause of breast milk jaundice is

Breast milk jaundice is a relatively common condition that affects newborn babies. While the exact cause is not fully understood, it is thought to be related to substances in breast milk, delayed gut maturation, hormonal changes, and genetic predisposition. With proper management, including continued breastfeeding, frequent feeding, and monitoring bilirubin levels, most infants with breast milk jaundice make a full recovery.

Breast milk jaundice can lead to complications if not managed properly, including: Breast milk jaundice occurs when components in human

Breast milk may contain high levels of an enzyme called beta-glucuronidase . This enzyme deconjugates bilirubin in the infant's intestines, allowing it to be reabsorbed into the bloodstream rather than being excreted through stool.

Unlike breastfeeding jaundice (caused by inadequate intake/dehydration), BMJ appears in a healthy, well-fed infant after the first 4–7 days, peaks in week 2, and can last several weeks. The core cause is not milk volume, but specific that interfere with the infant's liver metabolism of bilirubin.